NCT01943383View on ClinicalTrials.gov

Pharmacogenomic Evaluation of Antihypertensive Responses in Induced Pluripotent Stem (iPS) Cells Study

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Hypertension
Interventions
GENETIC

iPSC

Single blood draw for the production of induced pluripotent stem cells.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01943383 - Pharmacogenomic Evaluation of Antihypertensive Responses in Induced Pluripotent Stem (iPS) Cells Study | Biotech Hunter | Biotech Hunter